The cardiac glycosides market in Spain stood at 2.5 million USD PPP in 2023. The forecasted sales from 2024 to 2028 indicate a consistent decline, dropping from 2.3 million USD PPP in 2024 to 1.6 million USD PPP by 2028. The year-on-year variation shows a downward trend, with a -4.35% decrease from 2024 to 2025, a -9.09% drop from 2025 to 2026, -10% from 2026 to 2027, and -11% from 2027 to 2028. The compound annual growth rate (CAGR) over the five-year forecast period is -7.76%, reflecting a gradual decrease in the market.
Future trends to watch for include innovations in cardiac treatments, demographic shifts such as the aging population, and changes in healthcare policies that may impact the demand for cardiac glycosides. Advances in alternative therapies or changes in clinical guidelines could further influence market dynamics.
